Source comparison
Sermorelin vs HGH Secretagogues: Application-Specific Performance
Age-related GH decline models Restores physiological pulse amplitude without altering frequency; effective when GHRH receptors remain functional Bypasses age-related GHRH receptor downregulation; produces GH elevation regardless of endogenous GHRH capacity MK-
This comparison does not assign a generated winner or score.
- Age-related GH decline models
- Restores physiological pulse amplitude without altering frequency; effective when GHRH receptors remain functional
- Bypasses age-related GHRH receptor downregulation; produces GH elevation regardless of endogenous GHRH capacity
- MK-677 consistently outperforms in aged cohorts where GHRH responsiveness is impaired (>60% of subjects >65 years)
- Sleep architecture studies
- Amplifies endogenous nocturnal GH pulse during slow-wave sleep when timed correctly
- Elevates GH independent of sleep stage; may increase REM latency and alter sleep macrostructure
- Sermorelin preserves natural sleep-GH coupling; MK-677 introduces confounding sleep effects
- Appetite and metabolic research
- No direct orexigenic effect; GH metabolic effects isolated from ghrelin pathway
- Potent appetite stimulation via arcuate nucleus GHS-R1a; models ghrelin's role in energy homeostasis
- MK-677 essential for ghrelin pathway studies; sermorelin preferred when appetite must remain controlled
- Maximum GH output studies
- GH response limited by somatostatin tone and GHRH receptor density; ceiling effect observed
- Sustained supraphysiological GH elevation achievable; dose-response curve extends beyond sermorelin's ceiling
- Secretagogues produce 2–3× higher peak GH levels in head-to-head trials (25mg MK-677 vs 1mg sermorelin)
- Long-term IGF-1 modulation
- IGF-1 elevation mirrors natural pulsatile GH pattern; hepatic IGF-1 production remains feedback-regulated
- Sustained GH elevation produces stable IGF-1 increase but may desensitize hepatic GH receptors over 6+ months
- Sermorelin maintains physiological IGF-1 regulation; MK-677 requires monitoring for receptor downregulation
- CNS ghrelin receptor research
- Does not penetrate CNS; inappropriate for central ghrelin signaling studies
- Crosses blood-brain barrier; activates hippocampal and hypothalamic GHS-R1a
- Only MK-677 models central ghrelin effects; sermorelin limited to peripheral somatotroph activation